Four physician-scientists at Duke University School of Medicine have been recognized with prestigious 2026 early-career awards from the American Society of Clinical Investigation (ASCI), honoring their exceptional contributions to biomedical research and patient care.

A new $11.45 million award from the Nanaline H. Duke fund expands the ability of early-career physician-scientists at Duke to develop and innovate. The award will accelerate groundbreaking research that transforms patient care, while strengthening Duke’s role as a national leader in physician-scientist development, said Duke University President Vincent E. Price.

Faculty and staff from the School of Medicine and Duke Health are among the recipients of the prestigious 2025-26 Duke Presidential Awards. 

Duke researchers have found evidence that widely used drugs such as acetaminophen, proton pump inhibitors, and corticosteroids can reduce the efficacy of immunotherapy treatment.

The new center seeks to improve long-term outcomes for patients with or at risk for pancreatic cancer through esearch focusing on prevention, early detection, and treatment.

Cells inside our bodies divide constantly for growth and repair, but it’s a carefully controlled business. Mistakes can lead to diseases like cancer. 

In the wake of Hurricane Helene’s devastation across western North Carolina, families of children with intellectual and developmental disabilities face heightened challenges accessing essential health care and support services. To address these needs, Duke Psychiatry & Behavioral Sciences is partnering with local organizations to provide resources and coordinated care for these vulnerable communities.